Article

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in Canada

2024-12-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> With shifting epidemiology and changes in the vaccine funding landscape, resource use considerations for ongoing COVID-19 vaccination programs are increasingly important. We assessed the cost-effectiveness of COVID-19 vaccination programs, where eligibility is defined by combinations of age and chronic medical conditions, including a strategy similar to current Canadian reco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5e483dc9-7f8c-536e-8052-e351325bd680
DOI: 10.1101/2024.12.06.24318620

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-utility analysis of COVID-19 vaccination strategies for endemic SARS-CoV-2 circulation in CanadaDOI 10.1101/2024.12.06.24318620Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European RegionSemantic proximity Read

The Potential Clinical and Economic Impact of the Next-Generation COVID-19 mRNA-1283 Vaccine in CanadaSemantic proximity Read

Clinical and Economic impact of updated Fall 2023 COVID-19 vaccines in the Immunocompromised Population in CanadaSemantic proximity Read

Cost Effective Proactive Testing Strategies During COVID-19 Mass Vaccination: A Modelling StudySemantic proximity Read

Comparative effectiveness of mRNA-1273 versus protein-based NVX-CoV2705 vaccination on COVID-19-related outcomes among US insured adults during 2024–2025: a retrospective matched cohort studySemantic proximity Read

Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity Read

COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity Read

Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studySemantic proximity Read

Cost-effectiveness and cost-utility of COVID-19 vaccination in a South African privately insured population: a real-world claims-based analysisSemantic proximity Read

Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands – The VAccine Study COvid-19 (VASCO)Semantic proximity Read

Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United StatesSemantic proximity Read